Latest publications - highlights

New GA²LEN position paper: Risk of first-generation H1-antihistamines
M. K. Church, et al. Allergy 2010; DOI: 10.1111/j.1398-9995.2009.02325.x. Published on line on 8 February 2010.
Read the abstract - For more information, please contact office@ga2len.net

Unmet needs in severe chronic upper airway disease (SCUAD). 
Bousquet J, et al. on behalf of the extended Global Allergy and Asthma European Network, World Allergy Organization (WAO) and Allergic Rhinitis and its Impact on Asthma (ARIA) Study Group. 
J Allergy Clin Immunol 2009;124:428-33.

Results of the GA²LEN Skin Prick Test Study

• GA²LEN skin test study I: GA²LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. 
  L. M. Heinzerling, et al. Allergy 2009 October. Vol 64(10), pp. 1498-1506
• GA²LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. 
  G. J. Burbach, et al. Allergy 2009 October. Vol 64(10), pp. 1507-1515
• GA²LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients. 
  Bousquet PJ, et al. Allergy 2009 November. Vol 64(11), pp. 1656-62.

Recommendations for assessing Patient-Reported Outcomes and Health-Related quality of life in clinical trials on allergy: a GA²LEN taskforce position paper. 
Baiardini I, et al. Allergy 2009. 20 November 2009. Available online in advance of print

Urticaria guidelines update

• EAACI/GA²LEN/EDF/WAO guideline: management of urticaria. 
  Zuberbier T, et al. Allergy 2009 October. Vol 64(10): pp. 1427-43.
• EAACI/GA²LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. 
  Zuberbier et al. Allergy 2009 October. Vol 64(10): pp.1417-26. 

GA²LEN Publications 2004-2010

For more information on GA²LEN activities and publications, please contact office@ga2len.net.